卡博替尼+PD-L1.前列腺癌积极。

$伊克力西斯(EXEL)$ and Ipsen Announce Positive Results from Phase 3 CONTACT-02 Pivotal Trial Evaluating Cabozantinib+Atezolizumab vs 2nd Hormonal Therapy in mCRPC

co-primary of PFS met, +ve trend on co-primary of OS, FU continuing to next OS analysis